First, ALT serves as a well-established biomarker of hepatocellular injury and inflammation (13, 14); its elevation often precedes the onset of steatosis and reflects enhanced hepatic de novo lipogenesis (9, 22), which is frequently driven by excessive carbohydrate intake and insulin resistance (23, 24). This evidence concerns the gene INS and steatosis.